CODI-PC — Compass Diversified

Summary of Compass Diversified's Q4 2024 Earnings Call

1. Key Financial Results and Metrics

• Consolidated Net Sales: $620.3 million, up 13.8% year-over-year; pro forma sales growth of 8.9% after accounting for the Honey Pot acquisition.
• Adjusted EBITDA: $118 million, a 29% increase compared to Q4 2023, driven by strong operational performance across subsidiaries, despite a one-time inventory write-down of $11.8 million related to PFAS regulations.
• Net Income: $11.9 million, down from Q4 2023 due to a large gain from the sale of the Marucci business in the prior year.
• Adjusted Earnings: $46.6 million, up 34% year-over-year.
• Cash Flow from Operations: $9 million, with other businesses generating over $25 million excluding Lugano's cash usage.
• Balance Sheet: Ended Q4 with $60 million in cash and $490 million available on the revolver; total leverage ratio at 3.58x, improved from 4x a year ago.

2. Strategic Updates and Business Highlights

• Acquisitions: Acquired Honey Pot (feminine hygiene) and Lifoam (temperature-controlled packaging), while divesting Ergobaby and Crosman airgun businesses to optimize focus on innovative sectors.
• Capital Structure: Raised over $115 million in preferred equity to deleverage and reduce overall cost of capital; bought back over 400,000 shares in Q4.
• Management Fee Structure: Revised to align management compensation with shareholder interests, reducing long-term costs.
• Centers of Excellence: Established to enhance capabilities in areas like internal audit, sustainability, and AI.

3. Forward Guidance and Outlook

• 2025 Adjusted EBITDA Guidance: Expected to be between $480 million and $520 million, with subsidiary adjusted EBITDA between $570 million and $610 million.
• Branded Consumer Vertical: Expected adjusted EBITDA between $440 million and $465 million; industrial vertical forecasted at $130 million to $145 million.
• CapEx for 2025: Anticipated between $80 million to $90 million, focused on growth investments.

4. Bad News, Challenges, or Points of Concern

• PFAS Regulations Impact: 5.11 faced challenges due to regulatory write-downs, though these are expected to be resolved moving forward.
• Economic Uncertainty: Geopolitical risks, particularly related to tariffs and trade wars, may impact operations and M&A activity.
• Market Conditions: While there is a slight recovery in M&A activity, overall market conditions remain subdued, creating challenges in finding suitable acquisition targets.

5. Notable Q&A Insights

• Growth Drivers: Lugano is expected to continue strong growth, but management is cautious about forecasting specific rates. Other subsidiaries also contribute to branded growth.
• 5.11 Strategy: Plans to reinvigorate marketing and introduce new products to enhance growth, with a focus on direct-to-consumer strategies.
• Tariff Preparedness: The company has diversified its supply chain over the past few years to mitigate tariff impacts, positioning itself favorably compared to competitors.
• M&A Activity: Management anticipates a slight uptick in acquisition opportunities in 2025, contingent on macroeconomic conditions stabilizing.

Overall, CODI reported strong financial results for Q4 2024, with strategic initiatives aimed at long-term growth and value creation, despite facing regulatory and economic challenges. The outlook for 2025 remains cautiously optimistic with a focus on innovation and operational efficiency.